Boxman - please share where you got your info about Abbott being close to completion in incorporating Recaf technology into their architect platform. I called Aurelius and they could not confirm that! They did however, tell me that when Abbott originally got the blind test results, they were so impressive that Abbott questioned them and sent them back to Biocurex for confirmation and to assure them that there was no tricky involved! WOW! The results must have been tremendous. I also asked about the small upfront fee and was told that the deal was back loaded in royalties! Again, I would be interested in confirming that Abbott is close to completion incorporating Recaf!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.